Get a Cancer Battle Plan

When people are trying to get pests to leave the house, they make them as uncomfortable as possible – they set traps, remove food sources, spray chemicals - anything to send the message that they aren’t welcome. When police are trying to get bad guys to evacuate a house, they have the same approach. Do everything you can to make the environment inhospitable. No food, no water, no air conditioning, and maybe even a smoke bomb or two.
What does this have to do with cancer?
I’ve been reading “A Cancer Battle Plan: Strategies for Beating Cancer from a Recovered ‘Hopeless Case” by Anne Frahm and I’m fascinated. She talks about cancer, not as a thunderbolt of fate that drops from the sky, but a slowly developing invader looking for a hospitable environment. Her argument is that our typical American diet, exposure to many toxins and typical stress levels weaken our immunity to the invaders.
In it, she quotes Dr. Virginia Livngston-Wheeler, who says, “Cancer is a disease of the immune system. Or more accurately, it is a disease of a weak immune system. Your immunity must drop to very weak levels before cancer cells can grow, and when it drops to an extremely weak and low level, then cancer cells can spread.”
What are doing to make your body less hospitable?

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap